CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 268 enrolled
Drug / intervention
CST_001device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02256839
NCT02256839N/ACompleted

Evaluation of the 4th Generation QuantiFERON-TB Gold Test (CST001) for the Detection of Tuberculosis Infection

QIAGEN Gaithersburg, Inc·observational·Posted Oct 6, 2014·Updated Aug 1, 2019

In Brief

An observational study evaluating CST_001 for Tuberculosis. Completed, enrolled 268 participants across 1 site.

Detailed Summary

To compare the results of the investigational test to the currently approved QuantiFERON-TB Gold In-Tube test.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsTuberculosis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 6, 2014
Enrollment StartOct 1, 2014
Primary CompletionOct 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 11.7 years ago

Interventions

CST_001device